What question did this study set out to answer?

This research aims to clarify the role of SPHK2 in hepatic triglyceride regulation and its implications for fatty liver disease.

March 12, 2026

Noncanonical function of sphingosine kinase 2 (SPHK2) sustains hepatic triglyceride homeostasis.

Q: What does this research mean for the field?

SPHK2 attenuates hepatic steatosis by inhibiting ATGL ubiquitination and promoting triglyceride hydrolysis, indicating its therapeutic potential for MASLD. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Key Points

This research aims to clarify the role of SPHK2 in hepatic triglyceride regulation and its implications for fatty liver disease.
Investigated the noncanonical functions of SPHK2 in hepatic cells.
Assessed the impact of SPHK2 on ATGL ubiquitination and triglyceride breakdown.
SPHK2 inhibits the ubiquitination of ATGL, enhancing its activity.
The enzymatic function of SPHK2 is not required for its role in triglyceride homeostasis.

Abstract

SPHK2 attenuates hepatic steatosis by enzymatic-independently inhibiting ATGL ubiquitination and promoting triglyceride hydrolysis, indicating its therapeutic potential for MASLD.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Bingchuan Yuan

X Ding

Xinyu Deng

Actions

Institutions

Chinese Academy of Sciences

Harbin Medical University

Shanghai Institute of Materia Medica

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Noncanonical function of sphingosine kinase 2 (SPHK2) sustains hepatic triglyceride homeostasis.

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study